BioCentury
ARTICLE | Financial News

Naurex raises $80M in series C

December 4, 2014 2:58 AM UTC

Neurology play Naurex Inc. (Evanston, Ill.) raised $80 million in an untranched series C round with new investors Cowen; EcoR1 Capital; Goudy Park Capital; Portola Capital; and Sabby Capital. Existing investors Adams Street Partners; Baxter Ventures; Druid BioVentures; Genesys Capital; H. Lundbeck A/S (CSE:LUN); Latterell Venture Partners; Northwestern University; PathoCapital; Savitr Capital; and Takeda Ventures also participated.

Next year, Naurex plans to start a Phase III trial of lead program GLYX-13 to treat major depressive disorder (MDD). ...